Lifetime Management of the Aorta

January 7, 2023

Virtual via Zoom

Interactive didactic sessions from Rangos Auditorium, UPMC Children’s Hospital of Pittsburgh

Overview & Objectives

Aortic disease manifests itself in several different clinical presentations and stems from a wide range of underlying causes including genetic conditions, congenital anomalies, traumatic injury, and acquired disease.  Living with this complex disease can look very different for each unique patient—ranging from babies born with congenital aortic anomalies that will require various surgical interventions as their lifespan progresses, otherwise healthy adults who experience aortic aneurysm emergencies, to Marfan’s patients living with distinct physical characteristics and complications.

Lifetime Management of the Aorta brings together experts in pediatric and adult cardiology and cardiac surgery, adult congenital heart disease, genetics, cardiovascular imaging, vascular surgery and subspecialists in orthopedics and ophthalmology to explore current gold standard management techniques, strategies for overcoming complex medical management issues, technical pearls for challenging surgical interventions, and the importance of the provision of support resources for treatment of the aortic patient across the lifespan. Importantly, this course will explore the critical programmatic elements needed to facilitate truly integrated and comprehensive aortic care.

Who Should Attend

This course is designed for pediatric and adult cardiologists, cardiac surgeons, and trainees; adult congenital heart diseases specialists; geneticists; cardiothoracic radiologists and trainees; vascular surgeons and trainees; emergency medicine physicians and trainees; advanced practice providers; primary care providers; pediatricians; nurses; medical students; basic science and clinical research faculty and professionals; data and quality improvement healthcare professionals; healthcare administrators; and any other individuals interested in lifelong care of patients with aortic disease.

Registration

  • Registration information coming soon.

Course Directors:

Ibrahim Sultan, MD
Associate Professor of Cardiothoracic Surgery
Director, UPMC Center for Thoracic Aortic Disease
Surgical Director, UPMC Center for Heart Valve Disease
UPMC Heart and Vascular Institute

Arvind Hoskoppal, MD
Associate Professor of Pediatrics
Director, Adult Congenital Heart Disease Program
Heart Institute at UPMC Children’s Hospital of Pittsburgh
UPMC Heart and Vascular Institute

Rachel Torok, MD
Assistant Professor of Pediatrics
Heart Institute at UPMC Children’s Hospital of Pittsburgh
UPMC Heart and Vascular Institute

Michael J. Singh, MD
Associate Professor of Surgery
Director, Aortic Center, UPMC Heart and Vascular Institute
Associate Program Director, Vascular Residency and Fellowship Programs
UPMC Heart and Vascular Institute

Invited Faculty:

Thoralf Sundt, MD
Edward D. Churchill Professor of Surgery
Chief, Division of Cardiac Surgery
Director, Corrigan Minehan Heart Center
Co-director, Hypertrophic Cardiomyopathy Program
Massachusetts General Hospital
Harvard Medical School

Course Administrative Director:

Angela Kinnunen, MPA
HVI Project Manager
UPMC Heart and Vascular Institute

Course Administrative Coordinator:

Drew Berkhoudt, MBA
Project Specialist
Heart Institute at UPMC Children’s Hospital of Pittsburgh
UPMC Heart and Vascular Institute

More Information

To learn more about this course, please contact Angela Kinnunen at kinnunenae@upmc.edu.

Disclaimer Statement

The information presented at this CME program represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by, the UPMC Center for Continuing Education in the Health Sciences, UPMC / University of Pittsburgh Medical Center or Affiliates and University of Pittsburgh School of Medicine. Reasonable efforts have been taken intending for educational subject matter to be presented in a balanced, unbiased fashion and in compliance with regulatory requirements. However, each program attendee must always use his/her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.